Lindbrook Capital’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History
Bought
Maintained
Sold
Other funds holding ZEAL
FCM
AIC
SWM
Lindbrook Capital's ZEAL Position: Q4 2021 in Review
Lindbrook Capital sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q4 2021, closing a stake of 121 shares — an estimated $4K sold.
Lindbrook Capital first reported a position in ZEAL in Q1 2021 and held it in 3 quarters. The position peaked at $4K in Q3 2021. 12 funds tracked by Wall St. Rank hold ZEAL as of Q4 2021.
- Lindbrook Capital reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q4 2021 after selling out during the quarter.
- Lindbrook Capital sold 121 Zealand Pharma A/S American Depositary Shares shares in Q4 2021, an estimated $4K.
- Lindbrook Capital first reported a position in Zealand Pharma A/S American Depositary Shares in Q1 2021 and held it in 3 quarters.
- Lindbrook Capital's Zealand Pharma A/S American Depositary Shares position peaked at $4K in Q3 2021.
- 12 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q4 2021.
Based on Lindbrook Capital's 13F filing for Q4 2021, filed 18 Jan 2022.